Insights: Policy

ROAD to Housing Act (Housing Supply)

As noted earlier in the month, House Financial Services Committee (HFSC) Chair Hill (R-AK) and Ranking Member Waters (D-CA) are developing a modified version of the Senate-passed ROAD to Housing Act, the Senate’s housing supply bill. The homebuilding industry as well as other housing industry and advocacy groups have visibly raised concerns about...

CLARITY Act (Crypto Market Structure), Stablecoin Yield

Senate Banking Committee (SBC) Chair Scott (R-SC) has indicated that Republicans on the committee are close to fully unified in their support of the CLARITY Act, which provides a comprehensive regulatory framework for the crypto ecosystem. He said his goal is for the committee to vote on the bill in May and hopes the full Senate will take it up...

As we outlined in our 2/6 update, the policy risks to data center buildouts are primarily unfolding at the state level, which has most visibly manifested itself in Maine’s full ban on data centers. However, we are now seeing rapidly intensifying interest among federal policymakers in addressing the impact data centers are having on electricity...

Medical Devices/Medicare (RAPID)

CMS and the FDA have announced a new coverage pathway – known as the Regulatory Alignment for Predictable and Immediate Device (RAPID) pathway – designed to expedite access to certain Class II and Class III “Breakthrough Devices” for Medicare beneficiaries.

Drug Pricing/Most-Favored-Nation (MFN)

Senate Republicans are advancing reconciliation (partisan) legislation that would provide FY27 funding for U.S. Immigration and Customs Enforcement (ICE) and U.S. Customs and Border Protection (CBP). During the amendment votes on that bill, Senate Democrats forced Republicans to vote on two drug pricing proposals: one to codify...

Drug Pricing/Coverage (GLP-1s)

The CMS Innovation Center (CMMI) is revising and delaying portions of the launch of its Better Approaches to Lifestyle & Nutrition for Comprehensive hEalth (BALANCE) model, which will test Medicare/Medicaid coverage of GLP-1 drugs for weight loss purposes.